GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InVivo Therapeutics Holdings Corp (FRA:04I) » Definitions » FCF Yield %

InVivo Therapeutics Holdings (FRA:04I) FCF Yield % : -862.12 (As of May. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is InVivo Therapeutics Holdings FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, InVivo Therapeutics Holdings's Trailing 12-Month Free Cash Flow is €-9.50 Mil, and Market Cap is €0.85 Mil. Therefore, InVivo Therapeutics Holdings's FCF Yield % for today is -862.12%.

The historical rank and industry rank for InVivo Therapeutics Holdings's FCF Yield % or its related term are showing as below:

FRA:04I' s FCF Yield % Range Over the Past 10 Years
Min: -1489.46   Med: 0   Max: 0
Current: -862.12


FRA:04I's FCF Yield % is ranked worse than
98.01% of 1556 companies
in the Biotechnology industry
Industry Median: -14.055 vs FRA:04I: -862.12

InVivo Therapeutics Holdings's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.


InVivo Therapeutics Holdings FCF Yield % Historical Data

The historical data trend for InVivo Therapeutics Holdings's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InVivo Therapeutics Holdings FCF Yield % Chart

InVivo Therapeutics Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -92.03 -336.83 -57.92 -58.03 -187.96

InVivo Therapeutics Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -161.97 -155.96 -412.86 -243.85 -258.82

Competitive Comparison of InVivo Therapeutics Holdings's FCF Yield %

For the Biotechnology subindustry, InVivo Therapeutics Holdings's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InVivo Therapeutics Holdings's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InVivo Therapeutics Holdings's FCF Yield % distribution charts can be found below:

* The bar in red indicates where InVivo Therapeutics Holdings's FCF Yield % falls into.



InVivo Therapeutics Holdings FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

InVivo Therapeutics Holdings's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-10.046 / 5.34479
=-187.96%

InVivo Therapeutics Holdings's annualized FCF Yield % for the quarter that ended in Sep. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-2.138 * 4 / 3.3041988
=-258.82%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


InVivo Therapeutics Holdings FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


InVivo Therapeutics Holdings FCF Yield % Related Terms

Thank you for viewing the detailed overview of InVivo Therapeutics Holdings's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


InVivo Therapeutics Holdings (FRA:04I) Business Description

Traded in Other Exchanges
Address
One Kendall Square, Suite B14402, Building 1400 West, 4th Floor, Cambridge, MA, USA, 02139
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

InVivo Therapeutics Holdings (FRA:04I) Headlines

No Headlines